For researchers in immunology, inflammation, and rare disease research, choosing the best immunoassays and cell-based assays is critical for generating reliable, high-impact data. Our assays have been now featured in 600+ peer-reviewed scientific publications, demonstrating their role in biomarker discovery, clinical research, and drug development.
With this latest 2024 update to our publication list, you can now explore studies showcasing how our assays support groundbreaking discoveries, from basic research to approved therapies.